Therefore, it is possible that plasma NfL may replace t‐tau in an initial blood‐based diagnostic work‐up for AD to confirm the presence of neurodegeneration, followed by CSF t‐tau being used in tertiary centres to aid the confirmation of Aβ‐induced neurodegeneration. Here, NEFL is linked to Alzheimer disease.